Cambodia vs Kenya: Treatment coverage for schistosomiasis
Cambodia
76.0%
in 2024
Kenya
84.6%
in 2024
Cambodia rank
10th
Kenya rank
7th
Treatment coverage for schistosomiasis over time
- Cambodia
- Kenya
How they compare
Kenya currently reports 84.6% against 76.0% in Cambodia, a difference of 8.6%.
That makes Kenya's figure about 1.1 times Cambodia's.
The two have swapped places 1 time across 11 shared years of data; in 2013 it was Cambodia ahead.
Cambodia ranks 10th and Kenya ranks 7th of 45 countries.
Cambodia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80.2% | 20.5% | 59.6% | Cambodia |
| 2020s | 66.7% | 62.6% | 4.2% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Cambodia or Kenya?
- Kenya, at 84.6% against 76.0% in Cambodia as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Cambodia and Kenya?
- 8.6%, with Kenya ahead.
- How many years of comparable data are there for Cambodia and Kenya?
- 11 years are reported by both, from 2013 to 2024.
- How do Cambodia and Kenya rank globally for treatment coverage for schistosomiasis?
- Cambodia ranks 10th and Kenya ranks 7th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.